ReciBioPharm - An optimized Plasmid DNA platform to accelerate the path to clinic and commercialization

External Webinar | Webinar

Overview

  • Assessing key parameters of the upstream process to achieve high titer while maintaining  desired integrity.
  • Customizing the downstream process to address the different needs from supercoil plasmid and linear isoform.
  • A platform approach with integrated processes and analytical toolboxes to accelerate plasmid development to manufacturing.
This content is provided by Recipharm AB, and any views and opinions expressed do not necessarily reflect those of Outsourcing-Pharma.com

Speakers

Jing Zhu
Jing Zhu
Vice President, Nucleic Acid & Viral Vector Technology
AAV Process Development

View webinar

Thank you, you can now watch the webinar.

Latest Content

Take steps to stay in the serialization race

Take steps to stay in the serialization race

Paid for and content provided by Recipharm AB

As the deadline for drug serialization in the EU looms closer, it’s time to put the topic firmly on your agenda. Learn how to overcome the serialization challenge and simplify compliance.

Supplier Info Centre

Recipharm-AB.png

For more product information visit Recipharm AB.